703 Results for Nephrology near New York, NY

Dr. Canetta's Biography — Broad expertise in clinical nephrology focusing in particular on the diagnosis and management of glomerular diseases, including IgA nephropathy, lupus nephritis, renal vasculitis, membranoproliferative and C3 glomerulonephritis, membranous nephritis, focal segmental glomerulosclerosis and minimal change disease.

Dr. Jain's Biography — Dr. Namrata Jain, MD is a Pediatric Nephrology Specialist who practices in New York, NY. She is 36 years old and has been practicing for 11 years. Dr. Namrata Jain, MD is affiliated with NewYork-Presbyterian/Columbia University Medical Center.

Dr. Bomback's Biography — Andrew S. Bomback, MD, MPH is a nephrologist who specializes in glomerular diseases and resistant hypertension. Dr. Bomback received his undergraduate degree from Harvard University and his medical degree from Columbia University College of Physicians and Surgeons. He completed residency in Internal Medicine and fellowships in Nephrology and Clinical Epidemiology at the University of North Carolina at Chapel Hill, where he was the Doc J. Thurston III Fellow in Nephrology and Hypertension. In 2009, he returned to Columbia University as an associate at the Center for Glomerular Diseases. He is currently Assistant Professor of Medicine at Columbia University Medical Center. Dr. Bomback has published over 100 peer-reviewed articles and book chapters on the subjects of chronic kidney disease, glomerular diseases, and hypertension. He is the co-author of the textbook, Chronic Kidney Disease and Hypertension Essentials. He currently serves on the steering and publications committees for the National Kidney Foundation's Kidney Early Evaluation Program (KEEP). He is the recipient of the 2013 Daniel V. Kimberg Junior Faculty Award for oustanding teaching of medical students and housestaff. Dr. Bomback's research interests are evaluating novel therapies for glomerular diseases and further delineating the role of aldosterone in chronic kidney disease. He currently serves as principal or co-investigator on clinical trials of new treatments for IgA nephropathy, membranous nephropathy, lupus glomerulonephritis, C3 glomerulopathy, and focal segmental glomerulosclerosis.